Clinical Trial Update: Open-label Clinical Trial of Lacosamide in ALS [Phase 1, Phase 2]

View source ↗

Summary

Open-label clinical trial of lacosamide in amyotrophic lateral sclerosis has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Lacosamide (Lacosamide)

Snippet

Sponsor: Chiba University | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: COMPLETED